Efficacy and Safety of Stannsoporfin in Neonates

Exclusion criteria

• ✕. Born at the study hospital site and admitted to the well-baby nursery or admitted to the intensive-care nursery for \<12 hours for post delivery observation (delayed transition, temperature or dextrose instability, meconium staining and/or parental concern).
• ✕. All babies on oral feeding with stable cardiorespiratory status and deemed "healthy" upon clinical examination, with normal perfusion as defined by capillary filling of the fingernail.
• ✕. Term neonate (≥38 weeks of completed gestation), OR
• ✕. Near-term neonate (\>36\<38 weeks of completed gestation; \>2,000g birth weight), OR
• ✕. Near-term neonate (\>35\<38 weeks of completed gestation; \>2,500g birth weight)
• ✕. Care provided (primarily) in the well-baby nursery population;
• ✕0. Absence of concurrent cardiorespiratory distress, sepsis, major congenital anomalies or need for care in an intensive care nursery;
• ✕1. Not participating in another concurrent unrelated study.